Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
http://www.medicalnewstoday.com/articles/130227.php
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed randomized Phase 2 clinical trial of IMC-A12 in patients with previously treated HER2-expressing locally advanced or metastatic breast cancer has commenced patient enrollment.
Breast Cancer Drug Raises Blood Clot Risk, Should Have 'Black Box' Warning, JAMA Study Says
http://www.medicalnewstoday.com/articles/130130.php
<BR><A href="http://www.gene.com/gene/index.jsp?q=genentech&rls=com.microsoft:*&ie=UTF-8&oe=UTF-8&startIndex=&startPage=1" target=_new>Genentech</A>'s cancer drug Avastin -- which FDA approved in February for treatment of advanced breast cancer -- increases a patient's risk of developing blood clots in veins, a condition known as venous thromboembolism, or VTE, according to a <A href="http://jama.
Family History Raises Breast Cancer Risk Despite Absence Of BRCA Mutations, Study Finds
http://www.medicalnewstoday.com/articles/130129.php
<BR >Women with a strong family history of breast cancer have a four times greater risk for the disease than women in the general population, even if they do not carry a mutation of the BRCA gene, according to a study presented Monday at the <A href="http://www.
Causes Of Bone Loss In Breast Cancer Survivors Identified By Study
http://www.medicalnewstoday.com/articles/130119.php
Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.But a new study has found that cancer drugs aren't the only culprits.
----------------------------------------------
** CANCER / ONCOLOGY News **
Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
http://www.medicalnewstoday.com/articles/130227.php
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed randomized Phase 2 clinical trial of IMC-A12 in patients with previously treated HER2-expressing locally advanced or metastatic breast cancer has commenced patient enrollment.
Bovie Medical Corporation Announces FDA 510(K) Clearance To Market SEER Tissue Resection Device
http://www.medicalnewstoday.com/articles/130226.php
Bovie Medical Corporation (the "Company") (NYSE Alternext US: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company received 510(k) clearance from the Food and Drug Administration (FDA) to market its SEER tissue resection device intended for initial use in liver oncology surgery.
Relapsed Ovarian Cancer - Submitted New Drug Application To FDA For Trabectedin
http://www.medicalnewstoday.com/articles/130213.php
PharmaMar announced today that Ortho Biotech Products, L.P. has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL® (pegylated liposomal doxorubicin) for the treatment of women with relapsed ovarian cancer (ROC).
Gentium Provides An Update On The Phase 3 Treatment Trial Of Defibrotide For Severe Veno-Occlusive Disease
http://www.medicalnewstoday.com/articles/130209.php
Gentium S.p.A. (NASDAQ: GENT) announced today interim results from an independent Data Safety Monitoring Board (DSMB) review of the Company's Phase 3 treatment trial of Defibrotide for Severe Veno-Occlusive Disease (VOD).
Ovarian Cancer Cells Destroyed By New Platinum-Phosphate Compounds
http://www.medicalnewstoday.com/articles/130208.php
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal <i>Proceedings of the National Academy of Sciences</i>.
Higher Risk Of Certain Cancers Being Recorded In HIV-Positive People
http://www.medicalnewstoday.com/articles/130150.php
Physicians in the U.S. are reporting a higher risk for certain types of cancers -- such as liver, head, neck and lung -- in people living with HIV/AIDS, raising concerns that a cancer epidemic is imminent in the population, the <a href="http://www.
Common Virus Helps Quality Of Life For Sarcoma Patients Says Cancer Expert
http://www.medicalnewstoday.com/articles/130090.php
New data shows that some sarcoma patients are benefiting from treatment with REOLYSIN, developed from a harmless virus called the reovirus that most people are exposed to at some point in their lives.
Survival Of Head And Neck Cancer Patients Is Greatly Affected By Coexisting Ailments
http://www.medicalnewstoday.com/articles/130086.php
Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.
New Imaging Technique Tracks Cancer-Killing Cells Over Prolonged Period In First-Ever Stanford Case Study
http://www.medicalnewstoday.com/articles/130072.php
Coaxing a patient's own cells to hunt down and tackle infected or diseased cells is a promising therapeutic approach for many disorders. But until now, efforts to follow these specially modified cells after their reintroduction to the body have relied on short-term monitoring techniques that don't give a complete picture of the cells' status.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Mexican Department Of Public Health To Launch Screening For Papillomavirus, Cause Of Cervical Cancer
http://www.medicalnewstoday.com/articles/130083.php
In a campaign to significantly reduce the most common cancer affecting Mexican women, the Mexican Public Health Agency (Secretaria de Salud) announced that it is launching the first phase of a program that will offer free testing for human papillomavirus (HPV), the primary cause of cervical cancer, to all low-income women age 35-65.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Lymphoma Association Launches New Short Film
http://www.medicalnewstoday.com/articles/130121.php
The Lymphoma Association is delighted to launch their latest short film which shows the services they offer to anyone affected by lymphoma - the UK's sixth most common cancer. The charity were selected to have the film made for them for a nominal fee by the Media Trust, an organisation which helps charities raise awareness by providing them with volunteers from the TV, film and video industry who then produce videos for them.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
GenVec Announces Interim Survival Data In Pivotal Trial Of TNFerade™ In Locally Advanced Pancreatic Cancer
http://www.medicalnewstoday.com/articles/130229.php
GenVec, Inc. (Nasdaq:GNVC) announced today top-line results of an interim analysis from its ongoing Phase III Pancreatic Cancer Clinical Trial with TNFerade™ (PACT) in patients with locally advanced pancreatic cancer.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment